Vicki B Benard1, Meg Watson, Philip E Castle, Mona Saraiya. 1. Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. vdb9@cdc.gov
Abstract
OBJECTIVE: All national organizations now recommend that women be screened for cervical cancer beginning at age 21 years, regardless of age of sexual initiation; however, studies have shown that providers continue to screen much earlier than recommended. Two federal cancer surveillance systems were used to quantify the burden of invasive cervical carcinoma among women younger than 40 years of age. METHODS: We examined combined data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program covering 92% of the U.S. population. We calculated the age-adjusted incidence of cervical carcinoma among women younger than age 40 years by age, race, ethnicity, and histology for the time period of 1999-2008. RESULTS: For women younger than age 40 years, 78% of the cervical cancer cases were diagnosed in women aged 30-39, 21% were diagnosed in women 20-29 years of age, and 1% was diagnosed in women younger than age 20 years. There was an average of 3,063 cases of invasive cervical carcinomas annually from 1999 through 2008, with an average of 14 carcinomas per year (rate of 0.15 per 100,000 females) among those aged 15-19 years, and 125 carcinomas per year (rate of 1.4 per 100,000 females) among those aged 20-24 years. CONCLUSION: Cervical cancer is very rare in young women. Widespread implementation of Pap testing over the past four decades has detected very few cases of cervical cancer in women younger than 25 while potentially causing harm with unnecessary follow-up interventions. LEVEL OF EVIDENCE: III.
OBJECTIVE: All national organizations now recommend that women be screened for cervical cancer beginning at age 21 years, regardless of age of sexual initiation; however, studies have shown that providers continue to screen much earlier than recommended. Two federal cancer surveillance systems were used to quantify the burden of invasive cervical carcinoma among women younger than 40 years of age. METHODS: We examined combined data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program covering 92% of the U.S. population. We calculated the age-adjusted incidence of cervical carcinoma among women younger than age 40 years by age, race, ethnicity, and histology for the time period of 1999-2008. RESULTS: For women younger than age 40 years, 78% of the cervical cancer cases were diagnosed in women aged 30-39, 21% were diagnosed in women 20-29 years of age, and 1% was diagnosed in women younger than age 20 years. There was an average of 3,063 cases of invasive cervical carcinomas annually from 1999 through 2008, with an average of 14 carcinomas per year (rate of 0.15 per 100,000 females) among those aged 15-19 years, and 125 carcinomas per year (rate of 1.4 per 100,000 females) among those aged 20-24 years. CONCLUSION:Cervical cancer is very rare in young women. Widespread implementation of Pap testing over the past four decades has detected very few cases of cervical cancer in women younger than 25 while potentially causing harm with unnecessary follow-up interventions. LEVEL OF EVIDENCE: III.
Authors: Mona Saraiya; Faruque Ahmed; Sheila Krishnan; Thomas B Richards; Elizabeth R Unger; Herschel W Lawson Journal: Obstet Gynecol Date: 2007-02 Impact factor: 7.661
Authors: Xavier Castellsagué; Mireia Díaz; Silvia de Sanjosé; Nubia Muñoz; Rolando Herrero; Silvia Franceschi; Rosanna W Peeling; Rhoda Ashley; Jennifer S Smith; Peter J F Snijders; Chris J L M Meijer; F Xavier Bosch Journal: J Natl Cancer Inst Date: 2006-03-01 Impact factor: 13.506
Authors: Vicki B Benard; Herschel W Lawson; Christie R Eheman; Christa Anderson; William Helsel Journal: Obstet Gynecol Date: 2005-06 Impact factor: 7.661
Authors: A Hildesheim; O Hadjimichael; P E Schwartz; C M Wheeler; W Barnes; D M Lowell; J Willett; M Schiffman Journal: Am J Obstet Gynecol Date: 1999-03 Impact factor: 8.661
Authors: J J Carter; M M Madeleine; K Shera; S M Schwartz; K L Cushing-Haugen; G C Wipf; P Porter; J R Daling; J K McDougall; D A Galloway Journal: Cancer Res Date: 2001-03-01 Impact factor: 12.701
Authors: Kathleen K Thoburn; Robert R German; Mary Lewis; Phyllis Janie Nichols; Faruque Ahmed; Jeannette Jackson-Thompson Journal: Cancer Date: 2007-04-15 Impact factor: 6.860
Authors: N M Gray; L Sharp; S C Cotton; L F Masson; J Little; L G Walker; M Avis; Z Philips; I Russell; D Whynes; M Cruickshank; C M Woolley Journal: Br J Cancer Date: 2006-05-08 Impact factor: 7.640
Authors: Joseph H Oved; Ashley Graul; Robert A Burger; Lauren E Schwartz; M Carolina Reyes; Frank M Balis Journal: DNA Cell Biol Date: 2019-08-29 Impact factor: 3.311
Authors: Allison Kempe; Sean T O'Leary; Jo Ann Shoup; Shannon Stokley; Steven Lockhart; Anna Furniss; L Miriam Dickinson; Juliana Barnard; Matthew F Daley Journal: Pediatrics Date: 2016-02-26 Impact factor: 7.124
Authors: Lisa M Pollack; Donatus U Ekwueme; Mei-Chuan Hung; Jacqueline W Miller; Su-Hsin Chang Journal: Cancer Causes Control Date: 2020-05-20 Impact factor: 2.506
Authors: Silvia de Sanjose; Cosette M Wheeler; Wim G V Quint; William C Hunt; Nancy E Joste; Laia Alemany; F Xavier Bosch; Evan R Myers; Philip E Castle Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-04-30 Impact factor: 4.254
Authors: Vicki B Benard; Philip E Castle; Steven A Jenison; William C Hunt; Jane J Kim; Jack Cuzick; Ji-Hyun Lee; Ruofei Du; Michael Robertson; Scott Norville; Cosette M Wheeler Journal: JAMA Oncol Date: 2017-06-01 Impact factor: 31.777
Authors: Mario Jesus Trejo; Amr S Soliman; Yuli Chen; Mulele Kalima; Alick Chuba; Eslone Chama; Catherine K Mwaba; Lewis Banda; Kennedy Lishimpi Journal: Int J Gynaecol Obstet Date: 2021-07-14 Impact factor: 4.447